Investor's Business Daily on MSN13 分钟
Does AstraZeneca Have 'One Pill To Rule Them All' In Cholesterol?
AstraZeneca said Monday its experimental pill lowered "bad" LDL cholesterol by 51%. The results showed promise again rival drugs from Merck and NewAmsterdam Pharma, but AstraZeneca stock fell in line ...